MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611026927 A) filed by Akylo Healthcare Pvt. Ltd., Faridabad, Haryana, on March 7, for 'dual-drug loaded ultradeformable nanoparticulate hydrogel formulation and process for preparation thereof.'
Inventor(s) include Dr Manu Sharma; and Priyanka Singh.
The application for the patent was published on May 1, under issue no. 18/2026.
According to the abstract released by the Intellectual Property India: "The present invention discloses a dual-drug loaded nanoparticulate hydrogel formulation and a process for its preparation, specifically designed for the localized, non-invasive management of breast cancer via the transpapillary route. The formulation comprises ultradeformable vesicles (UDVs) consisting of soya lecithin and an edge activator (Span 80) which simultaneously encapsulate a hydrophilic chemotherapeutic agent (5-Fluorouracil) and a hydrophobic phytoestrogen (Biochanin A). These vesicles are incorporated into a stabilized Carbopol-934 hydrogel matrix to ensure prolonged skin contact and controlled drug release. The invention effectively reduces tumor burden and mitigates chemotherapy-induced systemic toxicity, offering a robust, synergistic, and patient-compliant strategy for targeted breast cancer therapy."
Disclaimer: Curated by HT Syndication.
